Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Republic of Korea.
Ann Thorac Surg. 2013 Jan;95(1):229-34. doi: 10.1016/j.athoracsur.2012.08.104. Epub 2012 Oct 25.
Primary pulmonary vein stenosis or atresia (PVS/A) is a rare entity with a high mortality rate. The aim of this study was to elucidate the clinical characteristics, progression, and prognostic factors of primary PVS/A in children.
We reviewed the medical records of patients who had primary PVS/A with normally connected pulmonary veins (PVs) at five pediatric cardiology centers in Korea between 1995 and 2010.
A total of 34 cases were identified. The median age at diagnosis was 12.0 months. During the follow-up period (median, 18 months; range, 2 to 185 months), PVS/A progressed to previously uninvolved veins in 9 patients. Surgical interventions were performed on 29 patients (venoplasty on 25 and pneumonectomy on 4). Nineteen of the patients who underwent venoplasty had restenosis after a median of 2 months. The sutureless technique did not reduce the rate of restenosis, progression of the disease to previously uninvolved PVs, or mortality rate. The mortality rate was 46.7%, the median age of death was 10.8 months, and the median interval between diagnosis and death was 3.0 months. In univariate analysis, predictors of death included involvement of at least three PVs, bilateral PV involvement, infancy-onset PVS/A, restenosis after surgery, and progression to previously uninvolved PVs. In multivariate analysis, significant risk factors for death were involvement of at least three PVs (hazard ratio, 8.8; p < 0.0001) and progression to uninvolved PVs (hazard ratio, 4.2; p = 0.014).
Primary PVS/A may carry a significant risk of recurrent and progressive PV obstruction or death even after surgical venoplasty.
原发性肺静脉狭窄或闭锁(PVS/A)是一种罕见的实体,死亡率很高。本研究旨在阐明儿童原发性 PVS/A 的临床特征、进展和预后因素。
我们回顾了韩国五家儿科心脏病学中心 1995 年至 2010 年间患有正常连接肺静脉(PVs)的原发性 PVS/A 的患者的病历。
共确定了 34 例。诊断时的中位年龄为 12.0 个月。在随访期间(中位数为 18 个月;范围为 2 至 185 个月),9 例患者的 PVS/A 进展至以前未受累的静脉。29 例患者接受了手术干预(25 例行血管成形术,4 例行肺切除术)。25 例行血管成形术的患者中有 19 例在中位时间为 2 个月后出现再狭窄。无缝线技术并不能降低再狭窄、疾病向以前未受累的 PV 进展或死亡率的发生率。死亡率为 46.7%,死亡的中位年龄为 10.8 个月,诊断和死亡之间的中位间隔为 3.0 个月。在单变量分析中,死亡的预测因素包括至少三条 PV 受累、双侧 PV 受累、婴儿期起病的 PVS/A、手术后再狭窄和以前未受累的 PV 进展。在多变量分析中,死亡的显著危险因素是至少三条 PV 受累(危险比,8.8;p<0.0001)和进展至未受累的 PV(危险比,4.2;p=0.014)。
即使在手术后进行血管成形术,原发性 PVS/A 也可能存在反复发生和进行性 PV 阻塞或死亡的风险。